Buwei Huang

Buwei Huang

Auto-generated profile, based on publicly available information

Buwei Huang

Department of Biochemistry, University of Washington

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNathaniel R. Bennett
Nathaniel R. Bennett
JWJoseph L. Watson
Joseph L. Watson
RRRobert J. Ragotte
Robert J. Ragotte
ABAndrew J. Borst
Andrew J. Borst
DSDéjenaé L. See
Déjenaé L. See
DBDavid Baker
David Baker
Despite the central role that antibodies play in modern medicine, there is currently no method to design novel antibodies that bind a specific epitope entirely in silico . Instead, antibody discovery currently relies on animal immunization or random library screening approaches. Here, we demonstrate that combining computational protein design using a fine-tuned RFdiffusion network alongside yeast display screening enables the generation of antibody variable heavy chains (VHHs) and single chain variable fragments (scFvs) that bind user-specified epitopes with atomic-level precision. To verify this, we experimentally characterized VHH binders to four disease-relevant epitopes using multiple orthogonal biophysical methods, including cryo-EM, which confirmed the proper Ig fold and binding pose of designed VHHs targeting influenza hemagglutinin and Clostridium difficile toxin B (TcdB). For the influenza-targeting VHH, high-resolution structural data further confirmed the accuracy of CDR loop conformations. While initial computational designs exhibit modest affinity, affinity maturation using OrthoRep enables production of single-digit nanomolar binders that maintain the intended epitope selectivity. We further demonstrate the de novo design of single-chain variable fragments (scFvs), creating binders to TcdB and a Phox2b peptide-MHC complex by combining designed heavy and light chain CDRs. Cryo-EM structural data confirmed the proper Ig fold and binding pose for two distinct TcdB scFvs, with high-resolution data for one design additionally verifying the atomically accurate conformations of all six CDR loops. Our approach establishes a framework for the rational computational design, screening, isolation, and characterization of fully de novo antibodies with atomic-level precision in both structure and epitope targeting.

6 December 2024 in Science
Verified
Journal Article
Closed access
MGMatthias Glögl
Matthias Glögl
AKAditya Krishnakumar
Aditya Krishnakumar
RRRobert J. Ragotte
Robert J. Ragotte
IGInna Goreshnik
Inna Goreshnik
BCBrian Coventry
Brian Coventry
DBDavid Baker
David Baker
Despite progress in designing protein-binding proteins, the shape matching of designs to targets is lower than in many native protein complexes, and design efforts have failed for the tumor necrosis factor receptor 1 (TNFR1) and other protein targets with relatively flat and polar surfaces. We hypothesized that free diffusion from random noise could generate shape-matched binders for challenging targets and tested this approach on TNFR1. We obtain designs with low picomolar affinity whose specificity can be completely switched to other family members using partial diffusion. Designs function as antagonists or as superagonists when presented at higher valency for OX40 and 4-1BB. The ability to design high-affinity and high-specificity antagonists and agonists for pharmacologically important targets in silico presages a coming era in protein design in which binders are made by computation rather than immunization or random screening approaches.

17 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNathaniel Bennett
Nathaniel Bennett
BCBrian Coventry
Brian Coventry
IGInna Goreshnik
Inna Goreshnik
BHBuwei Huang
Buwei Huang
AAAza Allen
Aza Allen
DBDavid Baker
David Baker
We explore the improvement of energy-based protein binder design using deep learning. We find that using AlphaFold2 or RoseTTAFold to assess the probability that a designed sequence adopts the designed monomer structure, and the probability that this structure binds the target as designed, increases design success rates nearly 10-fold. We find further that sequence design using ProteinMPNN rather than Rosetta considerably increases computational efficiency.

9 June 2025 in Advanced Materials
Verified
Journal Article
Open access
XWXinru Wang
Xinru Wang
JGJordi Guillem-Marti
Jordi Guillem-Marti
SKSaurav Kumar
Saurav Kumar
DLDavid S. Lee
David S. Lee
DCDaniel Cabrerizo‐Aguado
Daniel Cabrerizo‐Aguado
DBDavid Baker
David Baker
Integrin α5β1 is crucial for cell attachment and migration in development and tissue regeneration, and α5β1 binding proteins can have considerable utility in regenerative medicine and next‐generation therapeutics. We use computational protein design to create de novo α5β1‐specific modulating miniprotein binders, called NeoNectins, that bind to and stabilize the open state of α5β1. When immobilized onto titanium surfaces and throughout 3D hydrogels, the NeoNectins outperform native fibronectin (FN) and RGD peptides in enhancing cell attachment and spreading, and NeoNectin‐grafted titanium implants outperformed FN‐ and RGD‐grafted implants in animal models in promoting tissue integration and bone growth. NeoNectins should be broadly applicable for tissue engineering and biomedicine.

13 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAkaash Kumar
Akaash Kumar
KMKerrie E. McNally
Kerrie E. McNally
YZYuexuan Zhang
Yuexuan Zhang
AHAlex Haslett-Saunders
Alex Haslett-Saunders
XWXinru Wang
Xinru Wang
JMJames D. Manton
James D. Manton
Multispectral imaging is an established method to extend the number of colours usable in fluorescence imaging beyond the typical limit of three or four, but standard approaches are poorly suited to live-cell imaging. We introduce an approach for multispectral imaging in live cells, comprising an iterative spectral unmixing algorithm and eight channel camera-based image acquisition hardware. This enables the accurate unmixing of low signal-to-noise ratio datasets, typical of live-cell imaging, captured at video rates. We use this approach on a commercial spinning disk confocal microscope and a home-built oblique plane light sheet microscope to image 1–7 spectrally distinct fluorophore species simultaneously, using both fluorescent protein fusions and small-molecule dyes. We further use de novo designed protein-binding proteins (minibinders), labelled with organic fluorophores, and use these in combination with our multispectral imaging approach to study the endosomal trafficking of cell-surface receptors at endogenous levels.

19 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
JZJason Z Zhang
Jason Z Zhang
NGNathan Greenwood
Nathan Greenwood
JHJason Hernandez
Jason Hernandez
JCJosh T Cuperus
Josh T Cuperus
BHBuwei Huang
Buwei Huang
DBDavid Baker
David Baker
Protein quality control (PQC) is carried out in part by the chaperone Hsp70, in concert with adapters of the J-domain protein (JDP) family. The JDPs, also called Hsp40s, are thought to recruit Hsp70 into complexes with specific client proteins. However, the molecular principles regulating this process are not well understood. We describe the de novo design of a set of Hsp70 binding proteins that either inhibited or stimulated Hsp70’s ATPase activity; a stimulating design promoted the refolding of denatured luciferase in vitro , similar to native JDPs. Targeting of this design to intracellular condensates resulted in their nearly complete dissolution. The designs inform our understanding of chaperone structure-function relationships and provide a general and modular way to target PQC systems to condensates and other cellular targets.